Indo Us Bio-Tech Limited, a active public limited company, was established on 04 February 2004 in Ahmedabad, Gujarat, India. Engaging in seed production & distribution within the agriculture, forestry, fishing sector, it holds CIN: L01122GJ2004PLC043550. Registered under ROC Roc Ahmedabad. it is listed on BSE: 541304. It has an authorized capital of ₹32.00 Cr and a paid-up capital of ₹20.05 Cr.
Formerly known as Pellucid Bio-Tech Private Limited, Indo Us Bio-Tech Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹61.77 Cr and a net worth of ₹54.50 Cr. Employing 29 professional, Its leadership includes Shilpa Chetanbhai Thumar (Director), Nehaben Sachinbhai Patel (Director), Priyanka Jagdishbhai Ajudia (Director). Past directors included Dhiren Vithaldas Savalia, Gordhanbhai Karshanbhai Gangani, Shilpa Chetanbhai Thumar. It holds ₹28.79 Cr open charges and ₹17.46 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 309, Shanti Mall, Satadhar Char Rasta Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061.
L01122GJ2004PLC043550
043550
04 February 2004
₹32.00 Cr
₹20.05 Cr
Roc Ahmedabad
Listed (BSE: 541304)
Active
Explore comprehensive insights into Indo Us Bio-Tech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpa Chetanbhai Thumar | Director | 05 Aug 2021 | Current |
| Nehaben Sachinbhai Patel | Director | 05 Aug 2021 | Current |
| Priyanka Jagdishbhai Ajudia | Director | 23 Nov 2017 | Current |
| Malti Jagdishbhai Ajudia | Whole-Time Director | 01 Nov 2008 | Current |
| Jagdishkumar Devjibhai Ajudiya | Managing Director | 04 Feb 2004 | Current |
| Ritaben Nileshbhai Kikani | Director | 01 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2021 | Past |
| Pramod Abcsdd | Director | 10 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indo Us Bio-Tech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.95% increase. The company also saw a substantial improvement in profitability, with a 38.25% increase in profit. The company's net worth Soared by an impressive increase of 40.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Indo Us Bio-Tech had a promoter holding of 70.17% and a public holding of 29.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹287,850,000.00
₹174,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2025 | Axis Bank Limited | ₹25.23 Cr | Open |
| 18 Apr 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
| 20 Sep 2022 | Axis Bank Limited | ₹1.45 Cr | Open |
| 16 Jun 2022 | Others | ₹1.05 M | Open |
| 09 Nov 2019 | Others | ₹11.41 Cr | Satisfied |
Explore comprehensive loan charge details -
Indo Us Bio-Tech has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indo Us Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Us Bio-Tech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Indo Us Bio-Tech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 25.23 Cr with Charge ID 101127905 was registered on 24 Jun 2025. was completed.
The activity Indo Us Bio-Tech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100716412 was registered on 18 Apr 2023. was documented.
A charge registered on 09 Nov 2019 via Charge ID 100299902 with Others was fully satisfied on 10 Nov 2022. was recorded as a recent event.
The activity A charge registered on 21 Feb 2012 via Charge ID 10342992 with Dena Bank was fully satisfied on 10 Nov 2022. was completed.
The CIN of Indo Us Bio-Tech Limited is L01122GJ2004PLC043550.
Indo Us Bio-Tech Limited is headquartered at 309, Shanti Mall, Satadhar Char Rasta Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061.
Indo Us Bio-Tech Limited was incorporated on 04 February 2004.
The current directors of Indo Us Bio-Tech Limited are
The primary industry of Indo Us Bio-Tech Limited is Agriculture, Forestry, Fishing.
Indo Us Bio-Tech Limited is listed. It is listed on BSE: 541304.
The authorized capital of Indo Us Bio-Tech Limited is ₹32.00 Cr, and the paid-up capital is ₹20.05 Cr.
The compliance status of Indo Us Bio-Tech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX